Understanding Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Novartis NVS - P/E: 8.4
- Talkspace TALK - P/E: 1.43
- Organon OGN - P/E: 7.14
- BioNTech BNTX - P/E: 3.45
- Moderna MRNA - P/E: 5.21
Most recently, Novartis reported earnings per share at $1.56, whereas in Q1 earnings per share sat at $1.46. The company's most recent dividend yield sits at 2.54%, which has increased by 0.3% from 2.24% last quarter.
Talkspace's earnings per share for Q2 sits at $-0.15, whereas in Q1, they were at -0.13. Organon's earnings per share for Q2 sits at $1.25, whereas in Q1, they were at 1.65. Most recently, the company reported a dividend yield of 3.44%, which has increased by 0.07% from last quarter's yield of 3.37%.
BioNTech saw a decrease in earnings per share from 15.97 in Q1 to $6.87 now. Moderna's earnings per share for Q2 sits at $5.24, whereas in Q1, they were at 8.58.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.